Global Adrenocortical Carcinoma Drugs Market 2019-2023
- Published: Jul 2019
- Pages: 114
- SKU: IRTNTR31740
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global adrenocortical carcinoma drugs market size will grow by USD 259 million during 2019-2023. This market report provides a detailed analysis of the market by type (chemotherapy and targeted therapy) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Bristol-Myers Squibb Co., Eli Lilly and Co., Laboratoire HRA Pharma SAS, Progenics Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
Some of the key findings from our adrenocortical carcinoma drugs market forecast report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Global Adrenocortical Carcinoma Drugs Industry Overview
The adrenocortical carcinoma drugs market has recorded the development of several advanced imaging techniques, which are non-invasive and exhibit enhanced diagnostic accuracy in the detection of adrenal lesions. For instance, unenhanced computed tomography adrenal densitometry is used to differentiate adrenal adenomas from malignant lesions based on the presence of intracellular lipids. A combination of positron emission tomography/computed tomography is also gaining popularity among end-users for the identification of malignant and benign lesions. Similarly, multiphase computed tomography technique is being used to calculate absolute and relative percentage washout, and thereby, differentiate between benign and malignant lesions. Such advances in imaging techniques for adrenal tumors are identified as one of the critical adrenocortical carcinoma drugs market trends responsible for the growth of the market.
Chemotherapeutics such as mitotane, paclitaxel, 5-fluorouracil, and vincristine are used to treat adrenocortical carcinoma. Mitotane is also used in combination with cisplatin, doxorubicin, and etoposide, to treat adrenocortical carcinoma. However, chemotherapeutics and combination therapy are associated with various side-effects, including nausea and vomiting, peripheral neuropathy, seizures, anemia, and risk of infections. Moreover, chemotherapeutics treatment for adrenocortical carcinoma has low survival rates. These factors have driven researchers to develop novel therapies, which have minimum side-effects and are highly efficacious in the treatment of adrenocortical carcinoma. Hence, the development, approval, and advantages of novel drugs over chemotherapeutics will drive the growth of the adrenocortical carcinoma drugs market at a CAGR of over 6% during the forecast period.
Top Adrenocortical Carcinoma Drugs Companies Covered in this Market Research Report
The global adrenocortical carcinoma drugs market is concentrated. To help clients improve their market positions, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this adrenocortical carcinoma drugs market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.
The report offers a detailed analysis of several leading adrenocortical carcinoma drugs manufacturers, including:
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- Laboratoire HRA Pharma SAS
- Progenics Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
Adrenocortical Carcinoma Drugs Market Segmentation Based on Type
- Chemotherapy
- Targeted therapy
The chemotherapy segment will account for the highest adrenocortical carcinoma drugs market share. The rising focus on the development of combination therapies to treat adrenocortical carcinoma will fuel the growth of the market segment over the forecast period. This report provides an accurate prediction of the contribution of all the segments to the growth of the adrenocortical carcinoma drugs market size.
Adrenocortical Carcinoma Drugs Market Segmentation Based on Geographic Region
- Asia
- Europe
- North America
- ROW
With a complete study of the growth opportunities for the companies, it has been identified that North America will account for the highest share of the adrenocortical carcinoma drugs market throughout the forecast period. Factors such as the rising incidence of genetic syndromes, strong presence of vendors, and increasing R&D of drugs to treat adrenocortical carcinoma are responsible for adrenocortical carcinoma drugs market growth in this region.
Key Highlights of the Global Adrenocortical Carcinoma Drugs Market for the Forecast Years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the adrenocortical carcinoma drugs market during the next five years
- Precise estimation of the global adrenocortical carcinoma drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the adrenocortical carcinoma drugs industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of adrenocortical carcinoma drugs companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Chemotherapy - Market size and forecast 2018-2023
- Targeted therapy - Market size and forecast 2018-2023
- Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Increasing R&D for adrenocortical carcinoma
- Advances in imaging techniques for adrenal tumors
- Emergence of new diagnostic methods
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- Laboratoire HRA Pharma SAS
- Progenics Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
